Our magazine is free!

for living with diabetes

Protege drug — proposed autoimmune medication — trials suspended

Eli Lilly and MacroGenics announced that they have suspended phase III trials of Protégé, a drug designed to address the autoimmune component in people with Type 1 diabetes, according to an article form InPharma.

The companies pulled the plug in the drug because it did not meet its primary goal. The companies said that there were no unanticipated safety issues, but that safety monitoring among trial participants is warranted.

Sign up to our Magazine »

Leave a Comment

Submit Comment »

No Comments Yet!


nl-imageDirect to your inbox, our

free online magazine.

Sign up for the Desang Diabetes Magazine for new products, special offers and news.

*We will never email you more often than once a week (usually once a month). You can easily unsubscribe at any time. It’s finger-pricking good!

Close Don't show again